Rigel is a clinical-stage biotechnology company focused on the discovery and development of novel, small-molecule drugs for the treatment of inflammatory diseases, autoimmune diseases, and cancers

from http://www.rigel.com/rigel/corporate

Publications show all

Rigel Pharmaceuticals has published 59 articles.

Patents show all

701Applications623Issued

Clinical Trials show all

14Phase 23Phase 31Phase 11Phase 1/Phase 2

SEC Filings show all

8-K13910-Q4810-K16D1S-11

Contact Information